ImmunityBio (IBRX) Receivables - Other (2016 - 2025)
Historic Receivables - Other for ImmunityBio (IBRX) over the last 11 years, with Q3 2025 value amounting to $1.7 million.
- ImmunityBio's Receivables - Other rose 13086.42% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 13086.42%. This contributed to the annual value of $293000.0 for FY2024, which is 8548.79% down from last year.
- Latest data reveals that ImmunityBio reported Receivables - Other of $1.7 million as of Q3 2025, which was up 13086.42% from $204000.0 recorded in Q2 2025.
- ImmunityBio's 5-year Receivables - Other high stood at $5.0 million for Q3 2022, and its period low was $204000.0 during Q2 2025.
- Its 5-year average for Receivables - Other is $1.9 million, with a median of $1.8 million in 2022.
- Its Receivables - Other has fluctuated over the past 5 years, first skyrocketed by 171150.44% in 2021, then crashed by 8015.91% in 2025.
- Quarter analysis of 5 years shows ImmunityBio's Receivables - Other stood at $1.3 million in 2021, then skyrocketed by 41.79% to $1.9 million in 2022, then rose by 6.83% to $2.0 million in 2023, then tumbled by 63.89% to $729000.0 in 2024, then skyrocketed by 130.86% to $1.7 million in 2025.
- Its Receivables - Other stands at $1.7 million for Q3 2025, versus $204000.0 for Q2 2025 and $424000.0 for Q1 2025.